Lockheed Martin is set to report its third-quarter financial results before Tuesday's opening bell. Here's a look at what investors will be watching.

Some researchers are worried that a growing number of medical marijuana clinics are prioritizing profits over patient care.

Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance.

Buying $100 In NUE: If an investor had bought $100 of NUE stock 20 years ago, it would be worth $732.22 today based on a ...

Throughout the last three months, 5 analysts have evaluated Park Hotels & Resorts PK, offering a diverse set of opinions from ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $158.93, along ...

The general mood among these heavyweight investors is divided, with 48% leaning bullish and 39% bearish. Among these notable options, 227 are puts, totaling $13,267,202, and 714 are calls, amounting ...

A comprehensive examination of how financial experts perceive Warby Parker is derived from recent analyst actions. The ...

Today, Benzinga 's options scanner spotted 15 uncommon options trades for Sea. This isn't normal. The overall sentiment of ...

Martin Marietta Materials's MLM short percent of float has risen 20.38% since its last report. The company recently reported ...

PharmAla Biotech will supply GMP LaNeo MDMA to Mt. Sinai Health System for clinical research, advancing therapy for neurological disorders.

Analysts anticipate Quest Diagnostics to report an earnings per share (EPS) of $2.27. The announcement from Quest Diagnostics is eagerly anticipated, with investors seeking news of surpassing ...